Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Addict Med. 2015 Mar-Apr;9(2):87–93. doi: 10.1097/ADM.0000000000000093

High Rates of Abscesses and Chronic Wounds in Community-Recruited Injection Drug Users and Associated Risk Factors

Maria Elisa Smith 1, Natanya Robinowitz 2, Patrick Chaulk 2, Kristine E Johnson 1
PMCID: PMC4375012  NIHMSID: NIHMS635992  PMID: 25469653

Abstract

Objectives

Abscesses and chronic wounds are common among injection drug users (IDUs) though chronic wounds have been understudied. We assess the risk factors associated with both acute and chronic wounds within a community-based population of IDUs frequenting the Baltimore City Needle Exchange Program (BNEP).

Methods

We performed a cross-sectional study of BNEP clients ≥18 years who completed an in-person survey regarding active or prior wounds including abscesses (duration <8 weeks) and chronic wounds (duration ≥8 weeks), injection practices, and skin care. Factors associated with wounds were analyzed using univariate and multivariate logistic regression.

Results

Of the 152 participants, 63.2% were men, 49.3% were Caucasian, 44.7% were African American, 34.9% had any type of current wound, 17.8% had an active abscess, and 19.7% had a current chronic wound. Abscesses were more common in women (odds ratio [OR], 2.56; 95% confidence interval [CI], 1.10–5.97); and those reporting skin-popping (OR, 5.38; 95% CI, 1.85–15.67). In a multivariate model, risk factors for an abscess included injecting with a family member/partner (AOR, 4.06; 95% CI, 0.99–16.58). In a multivariable analysis of current chronic wounds, cleaning skin with alcohol prior to injection was protective (AOR, 0.061; 95% CI, 0.0064–0.58).

Conclusions

Abscesses and chronic wounds were prevalent among a sample of IDUs in Baltimore. Abscesses were associated with injection practices, and chronic wounds appeared linked to varying skin and tool cleaning practices. There is a pressing need for wound-related education and treatment efforts among IDUs who are at greatest risk for skin-related morbidity.

Keywords: Injection drug use, harm reduction, abscess, chronic wound, skin and soft tissue infection


Injection-related wounds, including abscesses and chronic wounds are significant causes of morbidity for injection drug users (IDUs) (Ebright & Pieper, 2002; Palfreyman et al., 2007). Skin and soft tissue infections (SSTIs), including cellulitis and abscesses, are the primary reason that IDUs present to emergency departments (EDs) (Palepu et al., 2001). Prior study has shown that IDUs treated for SSTIs in EDs faced a higher risk for future hospitalization and death (Binswanger et al., 2008). Injection-related wounds, which are generally perceived as low-acuity conditions, may be markers for greater addiction-related disease severity and poorer overall health status among IDUs.

Both behavioral and biological factors are thought to account for the high prevalence of wounds in this population. Repeated injection into the same anatomical site may lead to tissue and venous trauma, and bacterial inoculation may be facilitated under non-sterile situations. Vaso-constricting drugs, such as cocaine, injected either alone or in combination with heroin (i.e. speedballing) may induce vasospasm and thrombosis, leading to tissue necrosis (Ebright & Pieper, 2002; Hope et al., 2010; Murphy et al., 2001; Phillips & Stein, 2010; Spijkerman et al., 1996). Other possible risk factors for abscesses include skin-popping, defined as direct subcutaneous injection, and kicking (also known as booting or jacking), defined as injecting the drug into the vein, pulling blood into the syringe and then injecting it back into the vein (Binswanger, Kral, Bluthenthal, Rybold, & Edlin, 2000; Ebright & Pieper, 2002; Murphy et al., 2001; Phillips & Stein, 2010). Prior studies have suggested that women are at increased risk for developing abscesses (Ebright & Pieper, 2002; Fink, Lindsay, Slymen, Kral, & Bluthenthal, 2013; Hope, Marongiu, Parry, & Ncube, 2010; Lloyd-Smith et al., 2005; Lloyd-Smith et al., 2008; Spijkerman, van Ameijden, Mientjes, Coutinho, & van den Hoek, 1996) perhaps due to difficulty accessing veins, sharing of contaminated injection equipment, injection by someone else, and overlapping injection and sexual partners (Ebright & Pieper, 2002; Evans et al., 2003; Lum, Sears, & Guydish, 2005; Magnus et al., 2013; Tortu, McMahon, Hamid, & Neaigus, 2003; Wagner et al., 2010).

Vein injury occurs through scarring, non-sterile injection, and direct toxic effects of the drug and can lead to chronic venous insufficiency (CVI), which increases the risk for chronic lower extremity ulcers (Pieper & Templin, 2001; Pieper, Kirsner, Templin, & Birk, 2007). Wounds can also lead to more severe SSTIs, including gangrene and sepsis, potentially resulting in amputation or death (Callahan, Schecter, & Horn, 1998). Chronic wounds also have a social impact. The chronic pain, reduced mobility, malodor and stigma can marginalize these individuals and may make it difficult to maintain financial security and social support (Palfreyman et al., 2007; Pieper et al., 2007; Pieper, Templin, Goldberg, DiNardo, & Wells, 2013; Pieper, Templin, & Ebright, 2006). The prevalence of and risk factors for chronic ulcers in the IDU population has not been well studied or evaluated concurrently with risk factors for abscesses in this population.

The Baltimore City Health Department operates a mobile Needle Exchange Program (BNEP) in modified recreational vehicles that travel to fixed sites in the community six days per week (Gindi, Rucker, Serio-Chapman, & Sherman, 2009). We examined the prevalence and correlates for abscesses and chronic wounds in the IDU population accessing BNEP services to characterize the needs of the community and inform intervention strategies for this community and the broader IDU population.

METHODS

Study Design

We conducted a cross-sectional study among IDU clients of the BNEP, age ≥18 years, regardless of wound status. Data collection occurred between May 2012 and November 2013, and was conducted at five different exchange sites, though most participants were from Site A and Site B, which were 1.9 miles apart and demographically distinct. Site A is frequented primarily by African Americans and Site B is frequented primarily by Caucasians.

All participants provided written informed consent and completed a paper-administered survey including questions addressing demographics, injection behaviors, pre-injection skin care, wound history, wound care, and general medical history. Surveys required approximately 20 minutes, and upon completion, participants were given a $10 gift card for local businesses. Chronic wounds were defined as open areas on the skin that had been present and non-healing for ≥8 weeks. Abscesses were defined as swollen, red, painful lumps under the skin that may or may not be open and that have lasted <8 weeks. Study team members visually verified the presence of current abscesses and wounds at the time of the survey. This study was approved by the Johns Hopkins Medicine Institutional Review Board.

Data Analysis

Statistical analysis was performed using Stata 12 (StataCorp, College Station, TX). All survey variables were categorical except for age, which was a continuous variable. Survey variables were analyzed using χ2, univariate, multivariable and multinomial logistic regression. P values ≤0.05 were considered statistically significant. Covariates with P values ≤0.15 on univariate testing were included in multivariable models. Odds ratios predicting risk of outcome of abscess or chronic wound with 95% confidence intervals were assessed.

RESULTS

Demographics and Injection Behaviors

The 152 participants included 96 men (63.2%), 75 Caucasians (49.3%), and 68 African Americans (44.7%) (Table 1). The median age was 45 years with an interquartile range (IQR) of 35–52. These statistics were representative of the overall BNEP client population.

TABLE 1.

Description of Population for all Participants and by Current Wound Status


All participants (N=152)
Current Abscess (N=27)
Current Chronic Wounds (N=30)
Description No. (%) No. (%) No. (%)
Demographics
 Age* 45; (35–52) 44; (35–50) 45.5; (42–57)
 Gender
  Male 96 (63.2) 12 (44.4) 17 (56.7)
  Female 56 (36.8) 15 (55.6) 13 (43.3)
 Race
  Caucasian 75 (49.3) 17 (63.0) 12 (40.0)
  African American 68 (44.7) 8 (29.6) 15 (50.0)
  Native American 4 (2.6) 2 (7.4) 3 (10.0)
  Other or Multiple 5 (3.3) 0 (0.0) 0 (0.0)
 Housing
  Stable housing 113 (74.3) 21 (77.8) 25 (83.3)
  Unstable housing 39 (25.7) 6 (22.2) 5 (16.7)
Injection Practices
 Years injecting drugs
  ≤ 2 15 (9.9) 3 (11.1) 1 (3.3)
  3–8 25 (16.4) 6 (22.2) 2 (6.7)
  9–14 20 (13.2) 6 (22.2) 3 (10.0)
  ≥ 15 92 (60.5) 12 (44.4) 24 (80.0)
 Heroin
  Never 7 (4.6) 1 (3.7) 4 (13.3)
  Sometimes 24 (15.8) 1 (3.7) 4 (13.3)
  Every day 121 (79.6) 25 (92.6) 22 (73.3)
 Cocaine
  Never 53 (34.9) 9 (33.3) 11 (36.7)
  Sometimes 45 (29.6) 5 (18.5) 7 (23.3)
  Every day 54 (35.5) 13 (48.1) 12 (40.0)
 Speedball
  Never 49 (32.2) 8 (29.6) 9 (30.0)
  Sometimes 54 (35.5) 8 (29.6) 9 (30.0)
  Every day 49 (32.2) 11 (40.7) 12 (40.0)
 Skin-popping (N=151) 17 (11.3) 8 (29.6) 6 (20.0)
 Use of Filters 147 (96.7) 26 (96.3) 27 (90.0)
 With whom do you inject?
  Alone 77 (50.7) 9 (33.3) 16 (53.3)
  Friends 39 (25.7) 6 (22.2) 9 (30.0)
  Family member or partner 33 (21.7) 11 (40.7) 4 (13.3)
  Other 3 (2.0) 1 (3.7) 1 (3.3)
 Most frequent method of cleaning injection site before injecting
  Do not clean 35 (23.0) 7 (25.9) 10 (33.3)
  Water 12 (7.9) 2 (7.4) 1 (3.3)
  Soap/water 14 (9.2) 4 (14.8) 1 (3.3)
  Alcohol 83 (54.6) 13 (48.1) 16 (53.3)
  Other§ 8 (5.3) 1 (3.7) 1 (3.3)
*

Median; (Interquartile range).

Hispanic, Asian, multiple.

Unstable includes living in shelter, on the streets, in an abandoned unit, no set place, or multiple. Stable housing includes living in an owned/rented house, subsidized housing, with a friend, other (e.g. transitional house).

§

Including bleach, saliva, baby wipe, multiple agents.

The majority, 121 reported daily heroin use (79.6%) and nearly a third (n=49, 32.2%), reported daily use of speedball (mixture of heroin and cocaine) within the last thirty days. The majority of participants had lengthy addiction histories, having injected for over 15 years (n=92, 60.5%).

Although report of sharing needles was uncommon (n=125, 82.2%, never share), sharing of other injection tools was frequent. For example, 62 reported sharing spoons or cookers (40.8%), 55 shared water (36.2%), and 39/149 shared filters (26.7%). The most frequent method to clean the injection site before injection was topical alcohol (n=83, 54.6%). In the past 30 days, the median number of times clients used their own needles was three with an IQR of 1–4 (range, 1–50). Of the 111 clients (73.0%) who reported reusing their needles, all reported cleaning their needles prior to reuse with at least one agent: 56 used water only (50.5%), and 55 used bleach or a combination of bleach/water (49.5%).

Prevalence of Abscesses and Chronic Wounds

The prevalence of any active wound at the time of the interview, including abscesses and chronic wounds, was 34.9%, as seen in Table 2. Current chronic wounds were reported by 19.7% of participants (n=30). Current abscesses were reported by 17.8% of participants (n=27). Current wounds were self-reported and then visually verified by study staff at the time of the survey. Of clients without a current chronic wound (n=122), 19.7% reported having had a chronic wound in the past. Of the clients without a current abscess (n=125), more than half reported having at least one abscess anytime in the past. The burden of wound-related skin disease was calculated to include individuals either having a wound at the time of evaluation or anytime in the past. Without double counting individuals who had both current and past wounds, the wound-related skin disease burden in our population was 75.0% (n/N=114/152).

TABLE 2.

Abscess* and Chronic Wound Prevalence and Characteristics for all Participants and Separated by Gender and Race Categories

Gender
Race
All Participants (N = 152) Female (N = 56) Male (N = 96) Caucasian (N = 75) African American (N = 68) Native American (N = 4) Other (N = 5)







Description No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Current chronic wound 30 (19.7) 15 (26.8) 12 (12.5) 17 (22.7) 8 (11.8) 3 (75.0) 0 (0.0)
Current abscess 27 (17.8) 13 (23.2) 17 (17.7) 12 (16.0) 15 (22.1) 2 (50.0) 0 (0.0)
Chronic wound history ,§ 24 (19.7) 28 (68.3) 42 (50.0) 40 (69.0) 26 (43.3) 0 (0.0) 1 (20.0)
Abscess history , 70 (56.0) 7 (16.3) 17 (21.5) 14 (22.2) 9 (17.0) 1 (50.0) 3 (60.0)
Overall prevalence of wounds** 53 (34.9) 25 (44.6) 28 (29.2) 26 (34.7) 23 (33.8) 4 (100.0) 0 (0.0)
Current chronic wound location (N = 30) (N = 13) (N = 17) (N = 12) (N = 15) (N = 3) ***
 Arm 4 (13.3) 2 (15.4) 2 (11.8) 1 (8.3) 2 (13.3) 1 (33.3)
 Leg 19 (63.3) 8 (61.5) 11 (64.7) 7 (58.3) 10 (66.7) 2 (66.7)
 Buttocks 1 (3.3) 1 (7.7) 0 (0.0) 1 (8.3) 0 (0.0) 0 (0.0)
 Other 6 (20.0) 2 (15.4) 4 (23.5) 3 (25.0) 3 (20.0) 0 (0.0)
Current abscess location (N = 27) (N = 15) (N = 12) (N = 17) (N = 8) (N = 2) ***
 Arm 13 (48.1) 7 (46.7) 6 (50.0) 10 (58.8) 2 (25.0) 1 (50.0)
 Leg 7 (25.9) 4 (26.7) 3 (25.0) 4 (23.5) 2 (25.0) 1 (50.0)
 Hand 3 (11.1) 2 (13.3) 1 (8.3) 0 (0.0) 3 (37.5) 0 (0.0)
 Foot 3 (11.1) 2 (13.3) 1 (8.3) 2 (11.8) 1 (12.5) 0 (0.0)
 Groin 1 (3.7) 0 (0.0) 1 (8.3) 1 (5.9) 0 (0.0) 0 (0.0)
*

Defined as swollen lump under the skin lasting < 8 weeks, which is often red, warm, and painful. It may or may not have pus or be an open wound.

Defined as open areas on the skin lasting ≥ 8 weeks.

Clients who did not have a current wound were asked about their history with abscesses or chronic wounds. History included at least one prior wound that had healed before study evaluation. Number of participants answering history questions differs from general population N.

§

Chronic wound history – All: N=122; Females: N=43; Males: N=79; Caucasian: N=63; African American: N=53; Native American: N=1; Other: N=5.

Abscess History – All: N=125; Females: N=41; Males: N=84; Caucasian: N=58; African American: N=60; Native American: N=2; Other: N=5.

**

Current wounds only, including abscesses and chronic wounds.

***

Not applicable, N=0 for “Other” races.

Factors Associated with a Current Abscess

As shown in Table 3, factors associated with a current abscess on univariate analysis included being female (Odds ratio (OR), 2.56; 95% Confidence interval (CI), 1.10–5.97), skin-popping (OR, 5.38; 95% CI, 1.85–15.67), injecting with a family member or partner compared to injecting alone (OR, 3.78; 95% CI, 1.38–10.31), and kicking occasionally (OR, 3.09; 95% CI, 1.02–9.37). In the multivariable model, injecting with a family member or a partner (Adjusted odds ratio (AOR), 4.06; 95% CI, 0.99–16.58) and kicking occasionally (AOR, 4.88; 95% CI, 1.09–21.90) remained associated with having a current abscess.

TABLE 3.

Univariate and Multivariate Analysis of Factors Associated With a Current Abscess Among Clients of the Baltimore City Needle Exchange Program

Univariate
Multivariate (N=133)
OR 95% CI P OR 95% CI P
Gender
 Male Reference Reference
 Female 2.56 1.10–5.97 0.029* 2.35 0.72–7.64 0.156
Race
 African American Reference Reference
 Caucasian 2.20 0.88–5.49 0.091 2.21 0.64–7.58 0.207
 Native American 7.50 0.92–60.90 0.059 7.35 0.48–113.36 0.153
Skin Popping
 No Reference Reference
 Yes 5.38 1.85–15.67 0.002* 3.31 0.63–17.29 0.156
Sharing needles
 Never Reference Reference
 Occasionally 0.21 0.027–1.65 0.138 0.24 0.024–2.33 0.216
 Most of the time 1.40 0.14–14.08 0.774 0.74 0.014–39.52 0.881
 Every time 4.21 0.25–69.71 0.316 §
Kicking
 Never Reference Reference
 Occasionally 3.09 1.02–9.37 0.046* 4.88 1.09–21.90 0.039*
 Most of the time § §
 Every time 0.86 0.30–2.43 0.772 1.15 0.29–4.61 0.840
With whom do you inject?
 Alone Reference Reference
 Friends 1.37 0.45–4.18 0.576 1.66 0.42–6.47 0.467
 Family member or partner 3.78 1.38–10.31 0.009* 4.06 0.99–16.58 0.051*
Clean skin with soap before injection
 Never Reference Reference
 Occasionally 1.71 0.63–4.67 0.295 1.79 0.41–7.90 0.443
 Most of the time 3.91 0.99–15.52 0.052 6.50 0.72–59.00 0.096
 Every time 0.84 0.096–7.31 0.873 0.16 0.0053–4.58 0.281
Clean hands before injection
 Never Reference Reference
 Occasionally 2.13 0.72–6.33 0.174 2.30 0.54–9.86 0.262
 Most of the time 0.65 0.13–3.41 0.613 0.38 0.039–3.62 0.398
 Every time 2.47 0.82–7.41 0.107 2.04 0.39–10.57 0.395

Abbreviations: OR, odds ratio; CI, confidence interval.

This multivariate model includes variables from the univariate analysis that had at least one category with P ≤ 0.150.

Race categories of “Other” (Hispanic, Asian and multiple) had too few observations for both univariate and multivariate logistic regression.

§

Insufficient observations for univariate or multivariate logistic regression.

*

P ≤ 0.05 by logistic regression.

Factors Associated with a Current Chronic Wound

Presenting with a current chronic wound was associated on univariate analysis with identifying as Native American compared to African American (OR, 10.6; 95% CI, 1.03–109.45), injecting into the leg (OR, 3.12; 95% CI, 1.34–7.30) and cleaning needles with bleach or bleach/water combination before reuse, compared to cleaning needles with water only (OR, 4.44; 95% CI, 1.36–14.51), as shown in Table 4. Additionally, using filters appeared to be protective against having a current chronic wound (OR, 0.15; 95% CI, 0.024–0.94).

TABLE 4.

Univariate and Multivariate Analysis of Factors Associated With a Current Chronic Wound Among Clients of the Baltimore City Needle Exchange Program

Univariate
Multivariate (N=104)
OR 95% CI P OR 95% CI P
Age (years) 1.04 1.00–1.08 0.029* 0.88 0.78–0.99 0.032*
Race§
 African American Reference Reference
 Caucasian 0.67 0.29–1.56 0.357 0.38 0.053–2.74 0.337
 Native American 10.6 1.03–109.45 0.047* 128.1 1.86–8800.41 0.025*
Time injecting drugs (years)
 ≤ 2 Reference Reference
 3–8 1.22 0.10–14.69 0.877 2.19 0.058–82.49 0.671
 9–14 2.47 0.23–26.46 0.455 3.03 0.051–180.90 0.595
 ≥ 15 4.94 0.62–39.61 0.132 76.2 1.55–3753.56 0.029*
Skin Popping
 No Reference Reference
 Yes 2.63 0.88–7.84 0.082 3.12 0.41–23.82 0.273
Inject into leg
 No Reference Reference
 Yes 3.12 1.34–7.30 0.009* 3.17 0.56–18.10 0.194
Filter use
 No Reference Reference
 Yes 0.15 0.024–0.94 0.043* 0.11 0.0014–8.07 0.312
Cleaning skin before injection
 Do not clean Reference Reference
 Water 0.23 0.026–2.00 0.182 0.018 0.00054–0.60 0.025*
 Soap/Water 0.19 0.022–1.67 0.135 0.14 0.0058–3.18 0.215
 Alcohol 0.60 0.24–1.49 0.269 0.061 0.0064–0.58 0.015*
 Bleach ** **
 Saliva 2.50 0.14–43.97 0.531 0.22 0.0051–9.47 0.431
 Multiple 0.83 0.077–9.00 0.881 0.14 0.0043–4.63 0.272
Cleaning needle with bleach upon reuse
 Water Reference Reference
 Bleach 4.44 1.36–14.51 0.014* 17.9 2.14–149.95 0.008*

Abbreviations: OR, odds ratio; CI, confidence interval.

This multivariate model includes variables from the univariate analysis that had at least one category with P ≤ 0.150.

Continuous variable.

§

Race categories of “Other” (Hispanic, Asian and multiple) had too few observations for both univariate and multivariate logistic regression.

**

Insufficient observations for univariate or multivariate logistic regression.

*

P ≤ 0.05 by logistic regression.

The multivariable model for factors associated with current chronic wounds indicated that cleaning the skin with either water (AOR, 0.018; 95% CI 0.00054–0.60) or alcohol (AOR, 0.061; 95% CI, 0.0064–0.58) before injection reduced the odds of having a chronic wound (Table 4). Factors associated with chronic wounds in the multivariable model included identifying as Native American (AOR, 128.1; 95% CI, 1.86–8800.41), having an injection history ≥15 years (AOR, 76.2; 95% CI, 1.55–3753.56), and cleaning needles with bleach or bleach/water combination compared to water only at time of reuse (AOR 17.9; 95% CI, 2.14–149.95).

Factors Associated With a History of Abscess

Participants without active abscesses were asked about their history with prior abscesses. Among these individuals, a history of at least one abscess was associated on univariate analysis with Caucasians compared to African Americans (OR, 2.91; 95% CI, 1.37–6.18), and with injecting into the neck (OR, 6.62; 95% CI, 1.44–30.55). Compared to those who primarily visited BNEP Site A, those frequenting Site B were more likely to have an abscess history (OR, 2.51; 95% CI, 1.12–5.63). On univariate analysis, protective factors included cleaning skin with soap occasionally compared to never cleaning with soap before injection (OR, 0.26; 95% CI, 0.099–0.67).

Factors Associated With a History of Chronic Wound

For the participants who did not have a chronic wound at evaluation, a history of prior chronic wounds was associated with sharing filters (OR, 3.95; 95% CI, 1.53–10.16) and skin-popping (OR, 4.04; 95% CI, 1.12–14.59) at the univariate level. Skin-popping remained significant in the multivariable model (AOR, 7.04; 95% CI, 1.15–43.11).

Factors Associated With Female Gender and Current Abscess

We further evaluated injection practices by gender to understand the above-noted association between women and abscesses. After noting the potential influence of race and gender on current abscess risk, we compared African American men to Caucasian women. In this comparison, Caucasian women were at increased risk of having a current abscess (OR 3.52, 95% CI 1.16–10.64) and had similar risk for a history of abscesses (OR 3.54, 95% CI 1.27–9.86).

Across all women enrolled, reusing needles 5–7 times was associated with an 18.0–fold greater odds of having an abscess at evaluation compared to never reusing needles (95% CI 1.37–235.69). Compared to women who had injected for ≥15 years, less experienced female IDUs (injecting 9–14 years), had a 6.67 greater odds of presenting with a current abscess (95% CI 1.18–37.78). Finally, women who reported skin-popping had greater risk for a current abscess (OR 8.22, 95% CI 1.72–39.35) compared to women who denied skin-popping.

Although other socio-behavioral factors may explain women’s greater risk for abscesses, the covariates we measured were not significant by χ2 analysis. For example, compared to women without abscesses (n=41, 73.2%), women with abscesses (n=15, 26.8%) more often reported unstable housing (n=6, 40.0% versus n=6, 14.6%; P=0.119), using cigarette filters (n=9, 60.0% versus n/N=14/37, 37.8%; P=0.090), sharing spoons/cookers (n=9, 60.0% versus n=16, 39.0%; P=0.162), and sharing filters (n=6, 40.0% versus n=8, 19.5%; P=0.129). In addition, women with abscesses less often cleaned their skin with alcohol before injection (n=6, 40.0% versus n=26, 63.4%; P=0.185). Between these two groups of women, there were no significant differences in drug used or frequency thereof.

DISCUSSION

IDU participants in the BNEP harm reduction program have a high prevalence of current wounds (34.9%). This is consistent with prior reports and supports the need for focused interventions in the IDU population (Binswanger et al., 2000; Phillips & Stein, 2010).

Abscesses were associated with female gender (Fink et al., 2013; Hope et al., 2010; Lloyd-Smith et al., 2005; Spijkerman et al., 1996), kicking (Murphy et al., 2001), and skin-popping (Binswanger et al., 2000; Ebright & Pieper, 2002; Fink et al., 2013; Murphy et al., 2001; Phillips & Stein, 2010). We found that they were also associated with injecting in the company of a partner or family member. This finding suggests that there may be an ecology of common transmissible bacterial pathogens associated with skin infection, such as Staphylococcus aureus, among the immediate social network of IDUs (Quagliarello et al., 2002). The consistent finding of greater abscess risk in women may be physiological or related to social factors such as greater perceived security while injecting around family members or partners (Tortu et al., 2003; Wagner et al., 2010).

Abscesses were more frequent among women, especially Caucasian women. Among women of all races, those women with abscesses may have been less experienced with injection or safer injection practices overall. In addition to these factors, there may be additional unmeasured social and/or behavioral factors, including different injection habits, among Caucasian female IDUs in particular that may convey risk. Conversely, African American male IDUs may learn other, potentially skin-protective and safer injection habits not captured in this survey-based study. African Americans may have also had increased exposure to harm reduction messages over a longer period of time than Caucasians. The racial disparity in abscess prevalence observed here is consistent with prior study suggesting that Caucasians practice riskier injection behaviors compared to their African American peers (Bourgois et al., 2006; Williams et al., 2013).

Contrary to other studies, speedballing was not correlated with a current abscess or abscess history. We suspect that this is partly due to the racial differences in drug preference and abscess risk among our study participants, as African Americans more commonly reported daily use of speedball (data not shown), yet abscesses were marginally more common in Caucasians.

Chronic wounds in IDUs often persist due to the accumulation of venous trauma, which may partly explain why these wounds were associated with an injection history ≥ 15 years. Cleaning the skin with alcohol or even with water only before injection appeared protective against current chronic wounds. It is unclear why this hygiene measure was not significant in statistical models of the other wound outcomes. In contrast to cleaning the skin, cleaning needles with bleach upon reuse, versus using water, was associated with individuals who had a current chronic wound. This association might suggest that individuals with chronic wounds have different habits of local peri-injection skin care, possibly as a result of living with a chronic wound. Older individuals may have also internalized harm reduction messages over a longer period of time, perhaps influencing their behavior towards a type of needle cleaning advocated by harm reduction providers. Despite being more careful to clean needles before reuse, our analysis suggests that older individuals are less likely to clean their skin before injection. The reasons for these differences in pre-injection behavior among individuals with chronic wounds are unclear and suggest further study is necessary.

Our study had limitations. The survey was primarily conducted in the morning and early afternoons, potentially excluding more nocturnal clients. Participants were active members of the BNEP, and therefore they may report different injection and skin care practices than IDUs not accessing community-based harm reduction services and education. Our survey-based design also provided interesting associations that require further study. Finally, the survey relied upon self-reported data. Despite these potential limitations, we report for the first time risk factors for both acute and chronic wounds in a mobile metropolitan needle exchange program in Baltimore City. To our knowledge, acute and chronic wounds and their associated risk factors have not been evaluated jointly in comparable IDU populations.

CONCLUSIONS

Abscesses and chronic wounds are highly prevalent in the IDU community. Chronic wounds in IDUs in particular have been understudied. This study offers insight into behavioral, environmental and biological risk factors associated with these wound types, which can help guide intervention efforts. Future public health interventions to address abscesses and chronic wounds among IDUs should be targeted at especially vulnerable populations, including women and individuals reusing and cleaning needles. Additionally, there may be racial differences in access to wound care that require further study. Harm reduction education could stress the deleterious effect of skin-popping and kicking and raise awareness of injection-related, irreversible venous disease. Furthermore, specialized wound care services could improve the quality of life of IDUs given the high prevalence of wounds within this population. A sustainable, ongoing mobile wound program for IDUs may also limit healthcare costs by reducing unnecessary ER visits and hospitalizations through prompt treatment and prevention of secondary infections.

Acknowledgments

Source of Support:

This work was supported by The Johns Hopkins Undergraduate Woodrow Wilson Research Fellowship Program (MES), The Johns Hopkins University Center for AIDS Research, Baltimore HIV/AIDS Scholars Program 1P30A1094189 (MES), and The National Institutes of Health K23AI083100 (KEJ).

The authors would like to acknowledge the Baltimore City Health Department Office of Community Risk Reduction Services, the Needle Exchange Program staff, clients, and study participants, the Johns Hopkins Bayview Medical Center Division of Infectious Diseases, and the Johns Hopkins Wound Healing Center. We would also like to thank Dr. Susan Sherman for her thoughtful input. This work was supported by The Johns Hopkins University Woodrow Wilson Undergraduate Research Fellowship Program (MES); The Johns Hopkins University Center for AIDS Research, Baltimore HIV/AIDS Scholars Program 1P30A1094189 (MES); and The National Institutes of Health K23AI083100 (KEJ).

References

  1. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579–81. doi: 10.1086/313703. [DOI] [PubMed] [Google Scholar]
  2. Binswanger IA, Takahashi TA, Bradley K, Dellit TH, Benton KL, Merrill JO. Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death. J Stud Alcohol Drugs. 2008;69:924–32. doi: 10.15288/jsad.2008.69.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bourgois P, Martinez A, Kral A, Edlin BR, Schonberg J, Ciccarone D. Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. PLoS Med. 2006;3:1805–15. doi: 10.1371/journal.pmed.0030452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Callahan TE, Schecter WP, Horn JK. Necrotizing soft tissue infection masquerading as cutaneous abscess following illicit drug injection. Arch Surg. 1998;133:812–8. doi: 10.1001/archsurg.133.8.812. [DOI] [PubMed] [Google Scholar]
  5. Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am. 2002;16:697–712. doi: 10.1016/s0891-5520(02)00017-x. [DOI] [PubMed] [Google Scholar]
  6. Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study) J Urban Health. 2003;80:137–46. doi: 10.1093/jurban/jtg137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fink DS, Lindsay SP, Slymen DJ, Kral AH, Bluthenthal RN. Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities. Subst Use Misuse. 2013;48:523–31. doi: 10.3109/10826084.2013.787094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gindi RM, Rucker MG, Serio-Chapman CE, Sherman SG. Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, Maryland. Drug Alcohol Depend. 2009;103:93–8. doi: 10.1016/j.drugalcdep.2008.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hope V, Marongiu A, Parry J, Ncube F. The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiol Infect. 2010;138:1510–8. doi: 10.1017/S0950268810000324. [DOI] [PubMed] [Google Scholar]
  10. Lloyd-Smith E, Kerr T, Hogg RS, Li K, Montaner J, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J. 2005;2:24. doi: 10.1186/1477-7517-2-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405. doi: 10.1186/1471-2458-8-405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005;40:1681–96. doi: 10.1080/10826080500222834. [DOI] [PubMed] [Google Scholar]
  13. Magnus M, Kuo I, Phillips G, II, et al. Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Health. 2013;90:157–66. doi: 10.1007/s11524-012-9687-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. J Infect Dis. 2001;33:35–40. doi: 10.1086/320879. [DOI] [PubMed] [Google Scholar]
  15. Palepu A, Tyndall MW, Leon H, et al. Hospital utilization and costs in a cohort of injection drug users. Can Med Assoc J. 2001;165:415–20. [PMC free article] [PubMed] [Google Scholar]
  16. Palfreyman SJ, Tod AM, King B, Tomlinson D, Brazier JE, Michaels JA. Impact of intravenous drug use on quality of life for patients with venous ulcers. J Adv Nurs. 2007;58:458–67. doi: 10.1111/j.1365-2648.2007.04251.x. [DOI] [PubMed] [Google Scholar]
  17. Phillips KT, Stein MD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. Am J Drug Alcohol Abuse. 2010;36:92–7. doi: 10.3109/00952991003592311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pieper B, Kirsner RS, Templin TN, Birk TJ. Injection drug use: an understudied cause of venous disease. Arch Dermatol. 2007;143:1305–9. doi: 10.1001/archderm.143.10.1305. [DOI] [PubMed] [Google Scholar]
  19. Pieper B, Templin T. Chronic venous insufficiency in persons with a history of injection drug use. Res Nurs Health. 2001;24:423–32. doi: 10.1002/nur.1042. [DOI] [PubMed] [Google Scholar]
  20. Pieper BA, Templin T, Ebright JR. Ankle mobility in relation to chronic venous insufficiency in HIV-positive persons with and without a history of injection drug use. J Assoc Nurses AIDS Care. 2006;17:30–8. doi: 10.1016/j.jana.2006.05.003. [DOI] [PubMed] [Google Scholar]
  21. Pieper B, Templin TN, Goldberg A, DiNardo E, Wells M. Falls and balance confidence in persons with and without injection-related venous ulcers. J Addict Med. 2013;7:73–8. doi: 10.1097/ADM.0b013e31827ea882. [DOI] [PubMed] [Google Scholar]
  22. Quagliarello B, Cespedes C, Miller M, et al. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis. 2002;35:671–7. doi: 10.1086/342196. [DOI] [PubMed] [Google Scholar]
  23. Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–54. doi: 10.1016/0895-4356(96)00180-1. [DOI] [PubMed] [Google Scholar]
  24. Tortu S, McMahon JM, Hamid R, Neaigus A. Women’s drug injection practices in East Harlem: An event analysis in a high-risk community. AIDS Behav. 2003;7:317–28. doi: 10.1023/a:1025452021307. [DOI] [PubMed] [Google Scholar]
  25. Wagner KD, Lankenau SE, Palinkas LA, Richardson JL, Chou C, Unger JB. The perceived consequences of safer injection: an exploration of qualitative findings and gender differences. Psychol Health Med. 2010;15:560–73. doi: 10.1080/13548506.2010.498890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D. Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. J Acquir Immune Defic Syndr. 2013;63:S90–4. doi: 10.1097/QAI.0b013e3182921506. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES